Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma-Reference-Cited by-同舟云学术

Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma

Published:2018 Issue:10 Volume:58 Page:405-421
ISSN:0470-8105
Container-title:Neurologia medico-chirurgica
language:en
Short-container-title:Neurol. Med. Chir.(Tokyo)

Author:

JIAPAER Shabierjiang¹,FURUTA Takuya²,TANAKA Shingo¹,KITABAYASHI Tomohiro¹,NAKADA Mitsutoshi¹

Affiliation:

1. Department of Neurosurgery, Kanazawa University

2. Department of Pathology, Kurume University

Publisher

Japan Neurosurgical Society

Subject

Neurology (clinical),Surgery

Link

https://www.jstage.jst.go.jp/article/nmc/58/10/58_ra.2018-0141/_pdf

Reference154 articles.

1. 1) Yan Y, Xu Z, Dai S, Qian L, Sun L, Gong Z: Targeting autophagy to sensitive glioma to temozolomide treatment. J Exp Clin Cancer Res 35: 23, 2016

2. 2) Hirst TC, Vesterinen HM, Sena ES, Egan KJ, Macleod MR, Whittle IR: Systematic review and meta-analysis of temozolomide in animal models of glioma: was clinical efficacy predicted? Br J Cancer 108: 64–71, 2013

3. 3) Wen PY, Kesari S: Malignant gliomas in adults. N Engl J Med 359: 492–507, 2008

4. 4) Stevens MF, Hickman JA, Langdon SP, et al.: Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine. Cancer Res 47: 5846–5852, 1987

5. 5) Nanegrungsunk D, Onchan W, Chattipakorn N, Chattipakorn SC: Current evidence of temozolomide and bevacizumab in treatment of gliomas. Neurol Res 37: 167–183, 2015

Cited by 242 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detailed pathological role of non-coding RNAs (ncRNAs) in regulating drug resistance of glioblastoma; and update;Pathology - Research and Practice;2024-09

2. Modelling glioblastoma resistance to temozolomide. A mathematical model to simulate cellular adaptation in vitro;Computers in Biology and Medicine;2024-09

3. Glioma nanotherapy: Unleashing the synergy of dual-loaded DIM and TMZ;International Journal of Pharmaceutics;2024-09

4. Albumin-Based Microneedles for Spatiotemporal Delivery of Temozolomide and Niclosamide to Resistant Glioblastoma;ACS Applied Materials & Interfaces;2024-08-15

5. The Pro-Apoptotic Effect of Gemcitabine in Glioblastoma Multiform Cancer Model Induces by Tankyrase (TNKS) 1 Inhibitor XAV939 Through Autophagy Inhibition;2024-08-13